MAR 16, 2020 6:45 AM PDT

New diagnostic tech uses AI to screen blood for over 1400 pathogens

WRITTEN BY: Tara Fernandez

New and reemerging microbial threats continue to challenge the public health and infectious disease response teams worldwide. An estimated 14 million people a year die from infections and over half of these cases go undiagnosed. To accurately diagnose an infection, hospitals rely primarily on conventional microbiological methods: detecting the presence of antibodies in a patient’s blood, or culturing and identifying bacteria present in a biological sample. 

These tests take days and weeks to get any results. Ultimately, there is also a lingering possibility that despite undergoing a battery of tests, patients may never end up receiving any conclusive answers as to the underlying cause of their infection.

A new biotech startup called Karius has created technology that is set to revolutionize clinical diagnostics — scanning a single blood sample for over 1,400 known bacteria, fungi, viruses, and parasites, with physicians getting test results in a day. 

The platform uses genomic sequencing and screening, specifically detecting circulating genetic material originating from the infectious pathogen called microbial cell-free DNA (mcfDNA). These degraded fragments of DNA have emerged as a biomarker that point to the presence of an acute infection. Karius has developed a proprietary method for efficiently extracting the mcfDNA from blood samples and masking the signal from human DNA and any environmental bacterial contaminants to reveal the presence of any infectious agents.

Instead of having to rely on the expertise of trained personnel, the platform uses advanced machine learning algorithms to sift through the millions of complex genomic data points generated. With such artificial intelligence-driven systems, the diagnostic capabilities get more accurate and powerful over time as the platform is used more.

At $2,000 per run, the cost of running the test may, for now, be prohibitive for routine clinical diagnostics. However, the plummeting costs of DNA sequencing are a light at the end of the tunnel for allowing such genomic-based diagnostic tests to become more mainstream. For example, while the cost of sequencing the first human genome took $2.7 billion and almost 15 years to complete, today’s costs are below $1000.

Karius’ CEO Mickey Kertesz is optimistic, saying, “I see a future where genomics and technology like ours are completely displacing most, if not all, existing technologies.”

 



Sources: Fast Company, Karius.

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
OCT 19, 2020
Clinical & Molecular DX
Making Capillary Electrophoresis Accessible for Any Lab
OCT 19, 2020
Making Capillary Electrophoresis Accessible for Any Lab
Analyzing nucleic acids through gel electrophoresis has been a staple of genetic research for decades. But using traditi ...
OCT 22, 2020
Cardiology
Using Liposomes to Deliver Repair Packages to the Heart
OCT 22, 2020
Using Liposomes to Deliver Repair Packages to the Heart
The secret to any successful drug is not just its ability to treat a disease but its ability to target the disease exclu ...
DEC 01, 2020
Clinical & Molecular DX
Breathing New Life Into COVID Diagnostics
DEC 01, 2020
Breathing New Life Into COVID Diagnostics
Widespread diagnostic testing capacities are an absolutely critical tool for countries battling the pandemic. For now, m ...
DEC 08, 2020
Genetics & Genomics
Advancing Genetic Sequencing with Better Computational Tools
DEC 08, 2020
Advancing Genetic Sequencing with Better Computational Tools
The many advances that have propelled the field of genetics forward have taken a tremendous amount of work in different ...
JAN 07, 2021
Clinical & Molecular DX
Breath of Life: Nighttime Respiratory Rates Identify Which Heart Patients Need Surgery
JAN 07, 2021
Breath of Life: Nighttime Respiratory Rates Identify Which Heart Patients Need Surgery
Cardiovascular disease is the leading cause of death worldwide, taking nearly 18 million lives every year. Of these card ...
FEB 03, 2021
Clinical & Molecular DX
New Panel of Arthritis Biomarkers Diagnoses Disease With 93.2% Accuracy
FEB 03, 2021
New Panel of Arthritis Biomarkers Diagnoses Disease With 93.2% Accuracy
Rheumatoid arthritis, or RA, is a painful and debilitating autoimmune disorder of the joints, particularly those of the ...
Loading Comments...